The nationwide survey shows that slightly fewer than half of U.S. adults overall say they consider the Johnson & Johnson vaccine very or somewhat safe after its use was halted this month following reports of rare, severe blood clots.
The other two coronavirus vaccines authorized for emergency use in the United States, developed by Moderna and Pfizer and its German partner BioNTech, elicit significantly greater public confidence. More than 7 in 10 people say they regard each of those to be very or somewhat safe, the poll finds.
The unwillingness of about 3 in 4 unvaccinated U.S. adults to get the Johnson & Johnson shot points to hurdles facing the Biden administration and state and local public health officials in restarting use of a vaccine that was once heralded for its convenience.
Based on an assessment by a federal advisory committee that the vaccine’s benefits far exceed its risks, the Centers for Disease Control and Prevention and the Food and Drug Administration on Friday permitted the Johnson & Johnson vaccine to be administered again. It will be accompanied by a new warning on its label about the remote possibility of the dangerous blood clots, known to have formed in 15 U.S. recipients out of nearly 8 million doses given.
The Post-ABC poll was conducted April 18 to 21, before the pause was lifted. ...
The Post-ABC poll finds that 56 percent of U.S. adults say they had gotten at least one dose of a coronavirus vaccine.
Of the 44 percent who remain unvaccinated against the virus, a majority say they probably will not get a shot or definitely will not do so. ...
